沉默TRIM23基因抑制骨肉瘤细胞的增殖

目的 探讨TRIM23基因对骨肉瘤细胞增殖能力的影响.方法 应用Western blot实验检测TRIM23基因在骨肉瘤细胞中的表达;应用shRNA质粒转染骨肉瘤细胞系U2OS,通过MTT与平板克隆形成实验评估细胞增殖能力;应用Westernblot实验检测U2OS细胞Akt/P53/P21通路的表达改变.结果 TRIM23蛋白在骨肉瘤细胞中的表达高于成骨细胞;沉默TRIM23基因可以抑制骨肉瘤细胞的增殖能力;沉默TRIM23基因下调P-Akt表达,但总Akt的表达无明显改变,上调P53与P21的表达.结论 TRIM23在骨肉瘤细胞中表达升高,TRIM23能通过调节Akt/P53/P21通路影响骨肉瘤细胞的增殖.     

深圳市龙岗区大气污染物与医院呼吸系统疾病门诊量的广义相加模型分析

目的 探讨深圳市龙岗区主要大气污染物(SO₂、NO₂、PM₁₀与PM_2.5)与医院呼吸系统疾病门诊量的关系。 方法 收集2013年1月1日－2015年12月31日深圳市龙岗区2家公立医院呼吸系统疾病逐日门诊量资料,深圳市龙岗区逐日大气污染物浓度及逐日气象资料分别来自深圳市环境监测站及气象局,运用时间序列分析广义相加模型对大气污染物日均浓度与呼吸系统疾病门诊量的关系及滞后效应进行分析。 结果 深圳市龙岗区2013－2015年SO₂ 、NO₂ 、PM₁₀ 与PM_2.5浓度中位数分别为8.08、38.08、46.05 μg/m³及31.04 μg/m³。2家医院三年呼吸系统门诊总量为549 169人次,日门诊量中位数为499人次/d。广义相加模型分析结果表明,除NO₂对呼吸系统疾病门诊量影响差异无统计学意义外,其余三种污染物对呼吸系统疾病门诊量影响均存在滞后效应,污染物每升高10 μg/m³,滞后2 d时SO₂对门诊量影响最强(相对危险度RR为1.030 7,95%CI:1.015 7~1.045 9),滞后3 d时PM₁₀与PM_2.5浓度对呼吸系统疾病门诊量影响最强(PM₁₀:RR=1.005 4,95%CI:1.002 8~1.008 0,PM_2.5:RR=1.006 0, 95%CI:1.002 7~1.009 4)。 结论 深圳市龙岗区大气SO₂、PM₁₀与PM_2.5浓度对医院呼吸系统疾病门诊量影响存在滞后效应。     

Meeting 24-h Movement Guidelines is Related to Better Academic Achievement: Findings from the YRBS 2019 Cycle

This research is designed to investigate the relationship between the 24-h movement guidelines (24-HMG) and self-reported academic achievement (AA) using nationally representative data derived from the 2019 U.S. National Youth Risk Behaviour Survey. A multiple-stage cluster sampling procedure has been adopted to ensure a representative sample (N = 9127 adolescents; mean age = 15.7 years old; male% = 49.8%). Logistic regression has been adopted to obtain the odds ratio (OR) regarding the associations between adherence to 24-HMG and AA while controlling for ethnicity, body mass index, sex and age. The prevalence of meeting the 24-h movement guidelines in isolation and combination varied greatly (physical activity = 23.3%, screen time = 32.5%, sleep = 22.3%, and 24-HMG = 2.8%), while the percentage of highest-class AA was 42.5%. Compared with the situation when none of 24-HMG is met, the achievement of any of the combined guidelines (except for meeting the physical activity guidelines) was significantly associated with higher odds of achieving first-class AA. Meeting the sleep guideline had 1.42 times increased likelihood to achieve highest-class AA as compared with not meeting the sleep guideline. Meeting screen time guidelines and physical activity guidelines, respectively, were 1.32 and 1.13 times more likely to report first-class AA; but meeting the guidelines of physical activity was not significantly related to AA. Meeting the 24-HMG had the highest odds of achieving first-class AA (OR = 2.01, 95%CI: 1.47– 2.73). In both sexes, adolescents who met 24-HMG self-reported better AA (boys OR = 2.05, 95%CI: 1.34–3.15; girls OR = 2.26, 95%CI: 1.36–3.76). Significant relationships were observed in adolescents from 9–10th grade, but not higher grades. Our research findings suggest that optimal movement behaviours can be seen as an important This work is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. DOI: 10.32604/IJMHP.2021.017660 ARTICLE Tech Science Press Published Online: 26 October 2021 element to better academic achievement among U.S. adolescents. Future studies can adopt our discoveries to promote adolescents’ academic achievement through implementing optimal 24-h movement behaviour patterns.     

刺络联合舒利迭吸入疗法防治小儿哮喘的疗效观察

目的:探讨刺络联合舒利迭吸入疗法治疗小儿哮喘的临床疗效,并观察其用药前后的代谢组学变化。方法:选取2013年10月至2015年9月上海市宝山区中西医结合医院收治的哮喘患儿50例作为研究对象,按照随机数字表法随机分为对照组和观察组,每组25例。对照组采用沙美特罗替卡松粉吸入剂治疗,观察组在对照组治疗的基础上针刺四缝和少商穴位以及耳尖放血,间隔1 d进行1次,周期90 d。采集患儿用药前0 d,用药30 d,用药60 d,用药90 d的尿液,采用气相色谱-质谱联用技术(GC-MS)检测尿液内源性代谢物,观察治疗前后2组患儿临床症状评分、免疫指标以及代谢谱的变化情况。结果:观察组总有效率高于对照组,2组比较差异有统计学意义(P<0.05);与治疗前比较,2组患儿各项中医症候均明显减轻,观察组改善程度比对照组更为显著,差异有统计学意义,2组免疫学指标与治疗前比较均显著降低(P<0.05),与对照组比较(90 d),观察组(90 d)各指标降低程度更为明显,差异均有统计学意义(P<0.05)。采用有监督的分析-OPLS分析了治疗前对照组和观察组(0 d),治疗后(90 d)对照组和观察组的尿液代谢谱,结果显示4组代谢谱分离良好,鉴定了21个相关代谢标志物。结论:刺络联合舒利迭吸入疗法治疗小儿哮喘的临床效果确切,可改善患儿症状,降低免疫指标,其作用机制可能与丙氨酸,天冬氨酸和谷氨酸代谢、乙醛酸和二羧酸代谢和组氨酸代谢等代谢异常有关。     

扶正化痰固本方对早期非小细胞肺癌术后患者免疫功能的影响

目的:观察扶正化痰固本方运用于早期非小细胞肺癌术后的临床疗效及其对患者免疫功能的影响。方法:将70例早期非小细胞肺癌患者按照随机数字表法分为对照组和观察组,每组各35例。两组患者均接受肺癌切除术治疗,对照组术后3周开始接受MVP方案化疗,观察组在对照组的基础上加用扶正化痰固本方治疗。比较两组患者的临床疗效及治疗前后中医证候积分、卡氏评分(karnofsky performance status,KPS)及生活质量评分变化情况。检测两组患者治疗前后免疫功能指标、血清肿瘤标志物[癌胚抗原(carcinoembryonic antigen,CEA)、糖类抗原153(carbohydrate antigen 153,CA153)]水平。结果:观察组有效率为91.43%,对照组有效率为71.43%,两组患者有效率比较,差异具有统计学意义(P<0.05)。两组患者治疗后中医证候积分低于本组治疗前,且观察组治疗后低于对照组治疗后,差异具有统计学意义(P<0.05)。两组患者治疗后免疫功能指标检测结果低于本组治疗前,且观察组治疗后低于对照组治疗后,差异具有统计学意义(P<0.05)。两组患者治疗后血清CEA、CA153水平低于治疗前,KPS评分、QLQ-C30评分均高于治疗前,且观察组治疗后血清CEA、CA153水平低于对照组,KPS评分、QLQ-C30评分均高于对照组,差异具有统计学意义(P<0.05)。观察组胃肠道反应及骨髓抑制发生率均低于对照组,差异具有统计学意义(P<0.05)。结论:扶正化痰固本方运用于早期肺癌术后,能够有效改善患者免疫功能,减轻毒副反应,提高患者生活质量。